- Home
- INM vs FAMI Comparison
INM vs FAMI Comparison
Compare INM & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- FAMI
- Stock Information
- Founded
- INM 1981
- FAMI 2015
- Country
- INM Canada
- FAMI China
- Employees
- INM N/A
- FAMI N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- FAMI Packaged Foods
- Sector
- INM Health Care
- FAMI Consumer Staples
- Exchange
- INM Nasdaq
- FAMI Nasdaq
- Market Cap
- INM 5.0M
- FAMI 2.1M
- IPO Year
- INM N/A
- FAMI 2018
- Fundamental
- Price
- INM $1.85
- FAMI $1.68
- Analyst Decision
- INM
- FAMI
- Analyst Count
- INM 0
- FAMI 0
- Target Price
- INM N/A
- FAMI N/A
- AVG Volume (30 Days)
- INM 107.8K
- FAMI 47.2K
- Earning Date
- INM 11-13-2025
- FAMI 01-26-2026
- Dividend Yield
- INM N/A
- FAMI N/A
- EPS Growth
- INM N/A
- FAMI N/A
- EPS
- INM N/A
- FAMI N/A
- Revenue
- INM $4,942,633.00
- FAMI $43,831,754.00
- Revenue This Year
- INM N/A
- FAMI N/A
- Revenue Next Year
- INM N/A
- FAMI N/A
- P/E Ratio
- INM N/A
- FAMI N/A
- Revenue Growth
- INM 7.50
- FAMI N/A
- 52 Week Low
- INM $1.72
- FAMI $1.43
- 52 Week High
- INM $8.27
- FAMI $7.07
- Technical
- Relative Strength Index (RSI)
- INM 34.22
- FAMI 47.47
- Support Level
- INM $1.86
- FAMI $1.75
- Resistance Level
- INM $2.14
- FAMI $1.94
- Average True Range (ATR)
- INM 0.10
- FAMI 0.08
- MACD
- INM -0.02
- FAMI -0.00
- Stochastic Oscillator
- INM 8.75
- FAMI 37.50
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About FAMI Farmmi Inc.
Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.